Journal of Urology study shows long-term success for ImmunityBio's bladder cancer treatment; UAE grants world's broadest bladder cancer approval for Anktiva

A study published in the Journal of Urology revealed promising long-term results for ImmunityBio's bladder cancer treatment. The company also achieved the world's broadest bladder cancer approval as the UAE green-lit its lead drug.

Detected & updated continuously · Source: Nebula